Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis
- PMID: 15632380
- DOI: 10.1093/jnci/dji007
Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis
Abstract
Background: The PROGINS allele of the progesterone receptor (PGR) gene has been associated with an increased risk of ovarian cancer and a decreased risk of breast cancer. We set out to refine the association between common variation at the PGR gene locus and these two diseases.
Methods: We characterized the haplotype structure of the PGR gene by genotyping 54 single-nucleotide polymorphisms (SNPs) in 349 women. We then selected a subset of 17 haplotype-tagging SNPs that captured variation across the locus and typed them in 267 ovarian cancer case patients and 397 control subjects from two case-control studies and in 1715 breast cancer case patients and 2505 control subjects from a cohort study.
Results: The PGR locus was characterized by four blocks of strong linkage disequilibrium. Two SNPs in block 4 were associated with an increased risk of ovarian cancer among homozygous carriers as compared with noncarriers: rs1042838 (PROGINS allele; odds ratio [OR] = 3.23, 95% confidence interval [CI] = 1.19 to 8.75, P = .022) and rs608995 (minor allele; OR = 3.10, 95% CI = 1.63 to 5.89, P<.001). The PROGINS allele was observed on a subset of chromosomes carrying the minor allele at rs608995, and its association with ovarian cancer was fully explained by its association with rs608995. In addition, rs608995 fell on two common haplotypes (4-D and 4-E), whose association with ovarian cancer was the same as that of rs608995. These same two haplotypes were associated with a non-statistically significantly reduced risk of breast cancer.
Conclusions: Variation in PGR was associated with ovarian cancer risk, although the strongest result was not with the PROGINS allele. Instead, any causal allele(s) are likely in or downstream of block 4 and carried on haplotypes 4-D and 4-E. There was some evidence that the same variation was associated with a reduced risk of breast cancer, but the association was not statistically significant.
Similar articles
-
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.Breast Cancer Res Treat. 2008 May;109(1):91-9. doi: 10.1007/s10549-007-9627-3. Epub 2007 Jun 26. Breast Cancer Res Treat. 2008. PMID: 17592773
-
Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.Gynecol Oncol. 2006 May;101(2):287-95. doi: 10.1016/j.ygyno.2005.10.040. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360811
-
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.Hum Mol Genet. 2003 Oct 15;12(20):2679-92. doi: 10.1093/hmg/ddg294. Epub 2003 Aug 27. Hum Mol Genet. 2003. PMID: 12944421
-
Genetic epidemiology of breast cancer in younger women.J Natl Cancer Inst Monogr. 1994;(16):49-53. J Natl Cancer Inst Monogr. 1994. PMID: 7999469 Review.
-
Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.Endocrinology. 2023 Feb 11;164(4):bqad020. doi: 10.1210/endocr/bqad020. Endocrinology. 2023. PMID: 36702635 Free PMC article.
Cited by
-
Sex steroid-related candidate genes in psychiatric disorders.J Psychiatry Neurosci. 2008 Jul;33(4):319-30. J Psychiatry Neurosci. 2008. PMID: 18592033 Free PMC article. Review.
-
Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.Cancer Causes Control. 2010 Jun;21(6):897-908. doi: 10.1007/s10552-010-9518-5. Epub 2010 Feb 11. Cancer Causes Control. 2010. PMID: 20148360 Free PMC article.
-
Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.PLoS One. 2022 Jul 15;17(7):e0271265. doi: 10.1371/journal.pone.0271265. eCollection 2022. PLoS One. 2022. PMID: 35839271 Free PMC article.
-
Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.Pathol Oncol Res. 2020 Jan;26(1):141-147. doi: 10.1007/s12253-017-0379-z. Epub 2018 Jan 4. Pathol Oncol Res. 2020. PMID: 29302853
-
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.Br J Cancer. 2009 Mar 24;100(6):993-1001. doi: 10.1038/sj.bjc.6604947. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240718 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials